Product Information
PIFELTRO 100 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $60.7642 per EA under NDC 00006306901. Its NADAC has been published 349 times since Oct 23, 2019.
Strength
100 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006306901
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DORAVIRINEApproval Type
New Drug (NDA)
FDA Application
NDA210806On Market Since
7/20/2018
Pharmacological Classes
Price Statistics
The NADAC for PIFELTRO 100 MG TABLET has been published 349 times since Oct 23, 2019, and over the history we have for it it has risen 36.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $60.7642 per EA |
|---|---|
| All-time high | $60.9498 (May 13, 2026) |
| All-time low | $44.3183 (Nov 20, 2019) |
| 52-week high | $60.9498 |
| 52-week low | $59.3904 |
| Median price | $54.3347 |
| Average price | $53.2969 |
| Largest weekly change | +5.0% (Jan 15, 2020) |
| Weeks tracked | 349 |
| Tracking since | Oct 23, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the doravirine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PIFELTRO 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIFELTRO 100 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $60.7642 per EA (NDC 00006306901), effective Jun 24, 2026.
How has the price of PIFELTRO 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIFELTRO 100 MG TABLET has risen 36.1%. It has been tracked across 349 weekly CMS publications since Oct 23, 2019.
What are the highest and lowest recorded NADAC prices for PIFELTRO 100 MG TABLET?
Since Oct 23, 2019, the NADAC for PIFELTRO 100 MG TABLET has ranged from a low of $44.3183 (Nov 20, 2019) to a high of $60.9498 (May 13, 2026), with a median of $54.3347 per EA.
Are there cheaper alternatives to PIFELTRO 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PIFELTRO 100 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PIFELTRO 100 MG TABLET?
PIFELTRO 100 MG TABLET (NDC 00006306901) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification